Table 3.
Gene | Forward primer | Reverse primer |
---|---|---|
(A) | ||
CCL5 | CATCTGCCTCCCCATATTCCT | GCGGGCAATGTAGGCAAA |
CXCL11 | TGGTTACAGTGGAGACATTGACATT | GCTTTACGACACATAGATGCTTTTG |
IFIT2 | TGGCAAAAGATTGGACTAAGACACT | CCCAGCAATTCAGGTGTTAACA |
IFIT3 | TGAAGGAGAGCAGTTTGTTGAAGA | ACTGCGGAGGACATCTGTTTG |
HERC5 | GGGATGAAAGTGCTGAGGAGAAT | ACCCTGTGCAGCTTCTTCAAC |
OASL | ACCTGAGGATGGAGCAGAGAGT | CCCTGGTCTGGATGGTGAAG |
BIRC4BP | GAAAGCACCAAGAAGCAAAAACA | TGGGCTTGGGCTCTGACA |
NCF2 | CAGACCGAAAACCCCAGAGA | CAGGCACAAACCCAAATAGCA |
GBP4 | GGTTGCTTGTTTTTCGCTTGTAA | CCAACTATGCATCCAACAAAGATCTA |
PARP14 | CGACTGTGACCAGATAGTGAAGAGA | TTGGAGATGGTGGCATTGC |
ANGPTL1 | CTGCTGGGAGGTAACGAGATTC | TCAGGTGGTGGCATTAAATCTCT |
STAT1 | GCTGTCTGAAGGAAGAAAGGAAAA | CCGACTGAGCCTGATTAAATCTC |
IFIH1 | CCTTCCTCAGATACTGGGACTAACA | TTCTTCAGCTTTGGCTTGCTT |
TRIM14 | CAGAGAGCAACTTGACATCATGAAT | CGGGCTCCTGGCTGATACT |
RSAD2 | TGGTGAGGTTCTGCAAAGTAGA | TCACAGGAGATAGCGAGAATGTC |
(B) | ||
C8B | CAACCCAGCCATCATCAAAGT | GCAAAATCTGTGGCTGTCACTAGT |
CALN1 | CATCCCGCACCAGCATTT | GCACAGGCGGCAAAGCT |
GABRG2 | TCTCTGCTCTGGTGGAGTATGG | TCTTTGTCCTTGCTTGGTTTCC |
SLC38A4 | GCATTCTCAGAACATCAAACAAAAA | GCAAGACTGAGAGAAGACATTAAATGG |
GCNT3 | TTCTTGCTTCCCAAATGTCTTCA | GGACCAGGAGGCATAAACCA |
KLK13 | CAAAGACTCCTGTGAGGGTGACT | GGAGACGATGCCATACAGTGTTC |
ICOS | CCCTGGCCCTTCAAGATAGC | CATGCAGACAGGAAGTAGAGAAAATATT |
IL1F8 | TGGCTGGTTCCAGGATAGAGA | TGAACTCAGTCGCATAATGATCTG |
MASP2 | ATGCCGTCTATGAGCAAAAACA | TCAGGGTGCCCATTCGAAT |
15 up-regulated genes were selected for validation by RT-PCR.
9 down-regulated genes were selected for validation by RT-PCR.